Clinical Trial Update: Efficacy and Safety of SmofKabiven Peripheral Versus Compounded Emulsion [Phase 3]

View source ↗

Summary

Phase 3 trial comparing SmofKabiven peripheral administration to compounded emulsion for parenteral feeding; completed with efficacy and safety data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parenteral Nutrition-related Conditions
• Surgery-related Malnutrition

Drugs mentioned

• Compounded emulsion
• SmofKabiven

Snippet

Sponsor: Fresenius Kabi | Conditions: Parenteral Feeding, Surgery | Phase 3 | Status: COMPLETED